B2V1Y4 AF NFT

Probable chemoreceptor glutamine deamidase CheD

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiddh2axn2w4dxfhvzpafqu4n74qfukvcifoxk2ozshw6eruji7tau/metadata.json
IPFS of structure file: 
bafybeidhwzk2eooubh6kst4z4x5iool6j4adacden5j3fbi33b5zvsvp5u/AF-B2V1Y4-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xf4ED13986579E8e227b3ED6c02276c648754EC27
First NFT owner address (bech32): 
genesis17nk38xr9085wyfana4kqyfmvvjr4fmp80usw7n
Current NFT ID #61635 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
61635
Accession (UniProt):
B2V1Y4
Name::
Probable chemoreceptor glutamine deamidase CheD
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2V1Y4 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2V1Y4|CHED_CLOBA Probable chemoreceptor glutamine deamidase CheD OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=cheD PE=3 SV=1 MENTEVKVGIADLNLVSSPGKIMTIGLGSCIGIALYDRRSKLAGLSHIMLPDSTQFKNVTNPMKFADLAIPLLIKKMEAKGCLKRNLIAKIAGGASMFSFSDKSMVGDIGKRNIQAVKKSLSEERIQIIAEDVGGNKGRTMILDALDGKVTLKIVGIGIVEL